XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Earnings Per Share
13. Earnings Per Share
 
Basic earnings (loss) per share (EPS) is computed by dividing net income (loss) available to common stockholders by the weighted-average number of common shares outstanding. Diluted EPS is computed after adjusting the numerator and denominator of the basic EPS computation for the effects of all potentially dilutive common shares. The dilutive effect of options and non-vested stock issued under stock-based compensation plans is computed using the treasury stock method. The dilutive effect of the warrants is computed using the if-converted method.

Information related to the Company’s EPS calculations is summarized as follows: 
Three Months Ended September 30,Nine Months Ended September 30,
thousands except per share amounts2022202120222021
Net income (loss)
Net income (loss)$107,669 $2,117 $131,272 $(62,425)
Net (income) loss attributable to noncontrolling interests427 1,936 510 4,725 
Net income (loss) attributable to common stockholders$108,096 $4,053 $131,782 $(57,700)
Shares  
Weighted-average common shares outstanding - basic49,445 55,727 50,880 55,703 
Restricted stock and stock options26 29 32 — 
Weighted-average common shares outstanding - diluted49,471 55,756 50,912 55,703 
Net income (loss) per common share
Basic income (loss) per share$2.19 $0.07 $2.59 $(1.04)
Diluted income (loss) per share$2.19 $0.07 $2.59 $(1.04)

For the three months ended September 30, 2022, the diluted EPS computation excludes 254,987 shares of stock options and 422,132 shares of restricted stock because their effect is anti-dilutive. For the nine months ended September 30, 2022, the diluted EPS computation excludes 253,987 shares of stock options and 390,676 shares of restricted stock because their effect is anti-dilutive. For the three months ended September 30, 2021, the diluted EPS computation excludes 267,987 shares of stock options and 348,486 shares of restricted stock because their effect is anti-dilutive. For the nine months ended September 30, 2021, the diluted EPS computation excludes 286,487 shares of stock options and 465,574 shares of restricted stock because their effect is anti-dilutive. For all periods, the diluted EPS computation excludes 2,103,485 shares related to the O’Reilly Warrant, the Weinreb Warrant and the Herlitz Warrant because their effect is anti-dilutive.

Common Stock Repurchases In October 2021, the Company’s board of directors (Board) authorized a share repurchase program, pursuant to which the Company was authorized to purchase up to $250.0 million of its common stock through open-market transactions. During the fourth quarter of 2021, the Company repurchased 1,023,284 shares of its common stock, par value $0.01 per share, for $96.6 million, or approximately $94.42 per share. During the first quarter of 2022, the Company repurchased an additional 1,579,646 shares of its common stock, for $153.4 million, or approximately $97.10 per share, thereby completing all authorized purchases under the October 2021 program.

In March 2022, the Board, authorized an additional share repurchase program, pursuant to which the Company may, from time to time, purchase up to $250.0 million of its common stock through open-market transactions. The date and time of such repurchases will depend upon market conditions and the program may be suspended or discontinued at any time. During the first quarter of 2022, the Company repurchased 171,022 shares of its common stock, for $17.3 million, or approximately $101.09 per share under the March 2022 program. During the second quarter of 2022, the Company repurchased 2,164,400 shares of its common stock for $192.3 million, or approximately $88.83 per share. During the third quarter of 2022, the Company repurchased an additional 368,806 shares of its common stock for $25.4 million, or approximately $68.98 per share. This brings total share repurchases under the current $250.0 million authorization to approximately $235.0 million at an average price of $86.90 per share. All purchases were funded with cash on hand.